Compare Smith & Nephew plc (SNN) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Viavi Solutions Inc. Common Stock — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.10B), while Viavi Solutions Inc. Common Stock trades at $45.32 (market cap $10.85B). The key difference: Smith & Nephew plc and Viavi Solutions Inc. Common Stock are close in size by market cap, and Smith & Nephew plc pays a 2.95% dividend while Viavi Solutions Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| SNN | VIAV | |
|---|---|---|
Market Cap | $11.10B | $10.85B |
Volume | 1,051,703 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $37.17 | $55.33 |
52-Week Low | $26.42 | $12.27 |
Typical Hold Time | 121 Days | 1 Days |
Enterprise Value | $14.13B | $10.89B |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
